Take an in-depth look at San Diego's vibrant life sciences sector with our annual publication, Inside Biotech.
Life science companies such as Isis Pharmaceuticals (Nasdaq: ISIS) and Illumina (Nasdaq: ILMN) have been among the biggest occupiers of laboratory space during the past year, but are far from the only ones.
San Diego has seen its share of economic challenges, and its biotech industry is no exception. However, it's transformed and found profitable new opportunities on the near-term horizon. From our perspective, there are major trends worth considering as the area grows and raises capital.
Will they? Won't they? The ups and downs faced by two local publicly traded drug companies racing to get Food and Drug Administration (FDA) approval and be first to market with a new diet pill resembles a cliffhanger.
Law firms have always sought graduates with strong academic credentials. But in today’s rapidly evolving legal market, firms look for graduates with strong practical skills who can hit the ground running.
As Murrieta continues to grow as one of San Diego’s newest bedroom communities, the city is becoming more attractive to technology companies due to its quality of life, highly skilled work force, affordable land and buildings, full range of affordable housing, well respected schools, and its location at the intersection of interstates 15 and 215. Murrieta is located midway between San Diego and the Greater Los Angeles/Orange County metro region.
The Cushman & Wakefield Global Life Sciences Practice Group is San Diego County’s most experienced real estate team specializing exclusively in meeting the unique real estate needs of the area’s life science, pharmaceutical and clean tech companies.
The Food & Drug Administration is tightening its approval process, making it difficult for companies in an already tough economic environment to get investors.
San Diego-based Cardium Therapeutics announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market and sell the company's new Excellagen professional-use, sterile, syringe-based advanced wound care product.
The not-for-profit Scripps Health system and the human genome sequencing company Complete Genomics Inc. (Nasdaq: GNOM), announced a major collaboration Monday that will help further an ongoing scientific research initiative aimed at unlocking the genetic secrets of lifelong health.
Alan Gold, chairman and CEO of Rancho Bernardo-based BioMed Realty Trust said it isn't always easy to head one of the country's largest biomedical real estate investment trusts, but he wouldn't have it any other way.
An experimental flu medicine from San Diego-based NexBio Inc. reduced the virus in patients' blood by the second day of treatment, suggesting the drug may be an alternative to existing medications the virus has learned to evade.
The small companies that make up most of San Diego's life science sector are seeing their size as a double-edged sword as the recession wears on.
Learn about innovations and trends in San Diego’s thriving biotech and life science industries.
Explore the latest technologies, newest medical and drug discoveries, financing, IP issues and more.
Find out more about San Diego life science companies as we explore the latest technologies, drug discoveries, financing, IP updates and more.
The Daily Transcript takes an in-depth look at the biotech sector, including financing, educational needs and the latest research coming out of local companies.
This special report takes an in-depth look at the biotech sector of our local economy. We'll discuss what's going on in the biotech arena from many angles and explore the latest technologies used in drug discovery. We'll also review the latest intellectual property news.
The Women's Business Center of California Business to Business Expo is all about women-owned businesses showcasing their products and services to other women and the business community at large. The event will be held Thursday, Oct. 20, from 9:30 a.m. to 1 p.m. at National University, 9388 Lightwave Ave.